Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
about
Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenGene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.Comparison of 25-hydroxyvitamin D and Calcium Levels between Polycystic Ovarian Syndrome and Normal Women.Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus.Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary SyndromeGlucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary SyndromeCoagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary studyProteomics and polycystic ovary syndrome.Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.Transient neonatal Behcet's disease.A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease.Elevated circulating levels of tissue factor in polycystic ovary syndrome.Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.Should we individualize lipid profiling in women with polycystic ovary syndrome?
P2860
Q26851688-E581AB0C-60E1-430E-B8E3-0DC080B0A430Q27021307-D4EA5695-5AB3-44D2-8777-5F1734ECDD43Q33946386-2DBFCA25-CCCD-42CB-8A8D-50CD32F37CC3Q35534459-8BD10573-A638-42B3-B30F-8D4A67977335Q35538983-0BE723C7-A1B1-4F81-B663-6D57DD1BD74AQ35945451-2E4CF556-4449-4256-B46D-0C1C3A8FFC34Q36208271-C6F4B4A4-4FE6-48A4-AA04-62B0BADDE0F3Q36593085-528D17CF-4FC0-41A3-8186-8BE21AA22EE8Q36686554-2FCB3848-5E51-45F3-A034-1C90228D7141Q37226664-FCA99DD7-B009-495C-8448-22C963EA0D95Q38148579-EAB72CA1-36AB-4B0E-B3DF-E17A529DC3C1Q41628765-9F4FDB76-C700-4C99-93E1-A870B0CE924BQ41947342-A0D1A3F3-EB2E-4B03-BDA4-AC086A6433ACQ45796522-0EF08D9F-7976-482B-93EB-431B8708295FQ46658751-82EC2ACA-3CAF-45A6-A162-81BE75F31A9EQ47222891-6A2590B8-17EB-450A-973D-956855C37C0BQ47901277-B78802F3-36F6-41F2-B8C6-8CEF19084F5DQ54041492-F3F69665-67C9-4585-8609-A43A97B8F085
P2860
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
description
im April 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2011
@uk
name
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@en
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@nl
type
label
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@en
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@nl
prefLabel
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@en
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@nl
P2093
P50
P356
P1476
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
@en
P2093
Göran Holm
Louise Mannerås-Holm
Malin Lönn
Per Olof Janson
P304
P356
10.1210/JC.2010-2279
P407
P577
2011-04-01T00:00:00Z